Meta-analysis of the placebo response in antidepressant trials.

[1]  S. Brophy,et al.  Interventions for latent autoimmune diabetes (LADA) in adults. , 2011, The Cochrane database of systematic reviews.

[2]  A. Beekman,et al.  The three-year naturalistic course of major depressive disorder, dysthymic disorder and double depression. , 2009, Journal of affective disorders.

[3]  Dan Ariely,et al.  Commercial features of placebo and therapeutic efficacy. , 2008, JAMA.

[4]  Blair T. Johnson,et al.  Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration , 2008, PLoS medicine.

[5]  R. Rosenthal,et al.  Selective publication of antidepressant trials and its influence on apparent efficacy. , 2008, The New England journal of medicine.

[6]  Russell L. Kolts,et al.  Relationship Between Depression Severity Entry Criteria and Antidepressant Clinical Trial Outcomes , 2007, Biological Psychiatry.

[7]  H. Diener,et al.  Lessons from placebo effects in migraine treatment , 2007, The Journal of Headache and Pain.

[8]  Franz Porzsolt,et al.  The fading of reported effectiveness. A meta-analysis of randomised controlled trials , 2006, BMC medical research methodology.

[9]  R. Stern,et al.  The Effects of Manipulating Expectations Through Placebo and Nocebo Administration on Gastric Tachyarrhythmia and Motion-Induced Nausea , 2006, Psychosomatic medicine.

[10]  Fabrizio Benedetti,et al.  Loss of expectation-related mechanisms in Alzheimer’s disease makes analgesic therapies less effective , 2006, Pain.

[11]  C. Weiller,et al.  Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network , 2006, Pain.

[12]  M. Stoolmiller,et al.  The course of depressive symptoms in men from early adolescence to young adulthood: identifying latent trajectories and early predictors. , 2005, Journal of abnormal psychology.

[13]  S. Woods,et al.  Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorder. , 2004, The American journal of psychiatry.

[14]  D. Russell,et al.  Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. , 2004, Archives of general psychiatry.

[15]  S. Wessely,et al.  Active placebos versus antidepressants for depression. , 2004, The Cochrane database of systematic reviews.

[16]  F. Benedetti,et al.  Conscious Expectation and Unconscious Conditioning in Analgesic, Motor, and Hormonal Placebo/Nocebo Responses , 2003, The Journal of Neuroscience.

[17]  David A. Schoenfeld,et al.  The Problem of the Placebo Response in Clinical Trials for Psychiatric Disorders: Culprits, Possible Remedies, and a Novel Study Design Approach , 2003, Psychotherapy and Psychosomatics.

[18]  C. Ashton,et al.  A controlled trial of arthroscopic surgery for osteoarthritis of the knee. , 2002, The New England journal of medicine.

[19]  I. Kirsch,et al.  The Emperor's New Drugs: An Analysis of Antidepressant Medication Data Submitted to the U.S. Food and Drug Administration , 2002 .

[20]  P. Jerabek,et al.  The functional neuroanatomy of the placebo effect. , 2002, The American journal of psychiatry.

[21]  R. Sysko,et al.  Placebo response in studies of major depression: variable, substantial, and growing. , 2002, JAMA.

[22]  P. Petrovic,et al.  Placebo and Opioid Analgesia-- Imaging a Shared Neuronal Network , 2002, Science.

[23]  A. Hrõbjartsson,et al.  Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. , 2001, The New England journal of medicine.

[24]  M. Pollack,et al.  Is placebo response the same as drug response in panic disorder? , 2000, The American journal of psychiatry.

[25]  D. Reda,et al.  Placebo-associated blood pressure response and adverse effects in the treatment of hypertension: observations from a Department of Veterans Affairs Cooperative Study. , 2000, Archives of internal medicine.

[26]  W. Brown,et al.  Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. , 2000, Archives of general psychiatry.

[27]  I. Kirsch,et al.  Listening to Prozac but Hearing Placebo: A Meta-Analysis of Antidepressant Medication , 1998 .

[28]  George Davey Smith,et al.  Meta-analysis of randomised controlled trials , 1997, The Lancet.

[29]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[30]  R. Joffe,et al.  Antidepressant Treatment of Depression: A Metaanalysis , 1996, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[31]  F. Benedetti.  The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia , 1996, Pain.

[32]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[33]  T. Herzog,et al.  Psychotherapy of bulimia nervosa: what is effective? A meta-analysis. , 1992, Journal of psychosomatic research.

[34]  Betsy Jane Becker,et al.  Synthesizing standardized mean‐change measures , 1988 .

[35]  L. Hedges,et al.  Statistical Methods for Meta-Analysis , 1987 .

[36]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[37]  S. Wessely,et al.  Active placebos versus antidepressants for depression (Review) , 2004 .

[38]  A. Leuchter,et al.  Changes in brain function of depressed subjects during treatment with placebo. , 2002, The American journal of psychiatry.

[39]  A. Rush.  Treatment of major depression , 1993 .

[40]  W. Zung.  A SELF-RATING DEPRESSION SCALE. , 1965, Archives of general psychiatry.